PHARMACOECONOMICS AND OUTCOMES RESEARCH

被引：6

作者：

BOOTMAN, JL ^{[1
]}

机构：

[1] UNIV ARIZONA, CTR PHARMACEUT ECON, TUCSON, AZ 85721 USA

来源：

关键词：

D O I：

10.1093/ajhp/52.14_Suppl_3.S16

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S16 / S19

页数：4

共 22 条

[1] INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA - COST-BENEFIT-ANALYSIS
BOOTMAN, JL
WERTHEIMER, AI
ZASKE, D
ROWLAND, C
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) : 267 - 272
[2] BOOTMAN JL, 1991, PRINCIPLES PHARMACOE
[3] BOOTMAN JL, 1994, DRUG RELATED MORTALI
[4] BOOTMAN JL, 1995, PRINCIPLES PHARMACOE
[5] Drummond M, 1992, Pharmacoeconomics, V2, P1, DOI 10.2165/00019053-199202010-00001
[6] DRUG-RELATED HOSPITAL ADMISSIONS
EINARSON, TR
[J]. ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) : 832 - 840
[7] OPPORTUNITIES AND RESPONSIBILITIES IN PHARMACEUTICAL CARE
HEPLER, CD
STRAND, LM
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (03): : 533 - 543
[8] AVOIDING BIAS IN THE CONDUCT AND REPORTING OF COST-EFFECTIVENESS RESEARCH SPONSORED BY PHARMACEUTICAL COMPANIES
HILLMAN, AL
EISENBERG, JM
PAULY, MV
BLOOM, BS
GLICK, H
KINOSIAN, B
SCHWARTZ, JS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) : 1362 - 1365
[9] COST-OF-ILLNESS METHODOLOGY - A GUIDE TO CURRENT PRACTICES AND PROCEDURES
HODGSON, TA
MEINERS, MR
[J]. MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1982, 60 (03): : 429 - 462
[10] JUERGENS JP, 1992, AM J PHARM EDUC, V56, P135